APP and Alzheimer disease: These “first-generation” transgenic AD mouse models have been invaluable for delineating multifarious molecular mechanisms of disease onset and progression, but they share the limitation that the proteolytic processing of overexpressed APP results not only in the overproduction of Aß, but also of some other APP fragments.